Showing results (621-630 of 1,005) with videos related to
Sort By:
Pageof 101
Ejhaem|July 18, 2022
Acute myeloid leukemia in SRP54-mutated congenital neutropeniaAnthony Sabulski, David D Grier, Kasiani C Myers, et al.Ejhaem|July 18, 2022
Long-term remission of extramedullary cutaneous relapse of acute myeloid leukaemia (leukaemia cutis) treated with decitabine-venetoclaxDenise Maravalle, Alessandra Filosa, Catia Bigazzi, et al.Ejhaem|July 18, 2022
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasmsDaniele Vanni, Oscar Borsani, Yasuhito Nannya, et al.Ejhaem|July 18, 2022
Acalabrutinib-related second primary malignancies and nonmelanoma skin cancers in patients with chronic lymphocytic leukaemia (CLL): A systematic review and meta-analysis of randomised controlled trials (RCTs)Thura W Htut, Myat M Han, Kyaw Z TheinEjhaem|July 18, 2022
Overall survival with oral selinexor plus low-dose dexamethasone versus real-world therapy in triple-class-refractory multiple myelomaPaul G Richardson, Sundar Jagannath, Ajai Chari, et al.Ejhaem|July 18, 2022
Leg-type form of idiopathic multicentric Castleman disease associated with severe lower extremity chronic venous/lymphatic diseaseThomas Ballul, Nabil Belfeki, Adèle de Masson, et al.Ejhaem|July 18, 2022
Optimal time and threshold of absolute lymphocyte count recovery as a prognostic factor after single-unit cord blood transplantation in adultsTakaaki Konuma, Maki Monna-Oiwa, Kosuke Takano, et al.Ejhaem|July 18, 2022
Characterization of real-world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary centerJuha Ranti, Katariina Perkonoja, Tommi Kauko, et al.Ejhaem|July 18, 2022
"Ideal" parathyroid hormone in erythropoietin-stimulating agents-resistant anemiaBilal Ashraf, Taha Bat, Olga K Weinberg, et al.Ejhaem|July 18, 2022
The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?Michael R Cook, Judith E Karp, Catherine LaiPageof 101